| The kidney and hypertension: causes and treatment. | |
| | |
MedLine Citation:
|
PMID: 18607140 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Chronic kidney disease is both a cause and a consequence of hypertension. Extracellular volume expansion is an important, if not the most important, contributing factor to hypertension seen in chronic kidney disease. Beyond volume expansion, chronic kidney disease-related hypertension is without truly defining characteristics. Consequently, the sequencing of antihypertensive medications for the patient with chronic kidney disease and hypertension becomes arbitrary. Prescription practice in such patients should be mindful of the need for multiple drug classes with at least one of them being a diuretic. Blood pressure goals in the patient with chronic kidney disease and hypertension are set at lower levels than those for patients with essential hypertension alone. It remains to be determined to what level blood pressure should be lowered in the patient with chronic kidney disease, however. |
| | |
Authors:
|
Domenic A Sica |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of clinical hypertension (Greenwich, Conn.) Volume: 10 ISSN: 1524-6175 ISO Abbreviation: J Clin Hypertens (Greenwich) Publication Date: 2008 Jul |
Date Detail:
|
Created Date: 2008-07-08 Completed Date: 2008-10-24 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100888554 Medline TA: J Clin Hypertens (Greenwich) Country: United States |
Other Details:
|
Languages: eng Pagination: 541-8 Citation Subset: IM |
Affiliation:
|
Section of Clinical Pharmacology and Hypertension, Division of Nephrology, Virginia Commonwealth University Health System, Richmond, VA 23298-0160, USA. dsica@mcvh-vcu.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antihypertensive Agents
/
therapeutic use* Comorbidity Humans Hypertension, Renovascular / drug therapy, epidemiology, etiology*, physiopathology Kidney / physiopathology* Renal Insufficiency, Chronic / complications*, physiopathology Risk Factors United States / epidemiology |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Endocrine causes of secondary hypertension.
Next Document: Secondary hypertension: interfering substances.